ARCHIVES

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

Sharfstein To Leave FDA

January 7, 2011

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

In Brief: M.D. Anderson Selects Raphael Pollock To Lead Surgery Div.; S.F. VA Picks Norton

September 12, 1997